2,3-Dihydro-5-methyl-3-thiophenethiol
Common Name: |
2,3-Dihydro-5-methyl-3-thiophenethiol |
IUPAC Name: |
5-methyl-2,3-dihydrothiophene-3-thiol |
Molecular Formula: |
C11H24OS |
SMILES: |
CC1=CC(CS1)S |
Inchi: |
1S/C5H8S2/c1-4-2-5(6)3-7-4/h2,5-6H,3H2,1H3 |
Inchi Key: |
XMTPGJJWJZMORB-UHFFFAOYSA-N |
Cas No: |
56079-02-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
204.37 |
Mass (g/mol) |
132.007 |
Molar Refractivity |
64.08 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
8 |
Rings |
1 |
TPSA |
59.03 |
Hetero Atoms |
2 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
220.00 to 221.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.164 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
1.935 |
iLOGP |
3.05 |
XLOGP3 |
4.09 |
WLOGP |
3.42 |
MLOGP |
3.13 |
ESOL Log S |
-3.16 |
ESOL Solubility (mg/ml) |
0.143 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-5.04 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.13 |
Silicos-IT Solubility (mg/ml) |
0.15 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.64 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.567 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.322 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |